Daniel Ferraz de Campos Mazo

Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study

Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Luca Miele et al. · Nutrition Metabolism and Cardiovascular Diseases · 2017 · 135 citations · Full text

Life Sciences, Microbiology, Nutritional Sciences +17

Combination of <i>N</i> ‐acetylcysteine and metformin improves histological steatosis and fibrosis in patients with non‐alcoholic steatohepatitis

Cláudia P. Oliveira, José Tadeu Stefano, Érika Rabelo Forte de Siqueira et al. · Hepatology Research · 2007 · 108 citations

Medicine, Pharmacology, Pharmacotherapy +17

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 93 citations · Full text

Pharmacy, Immunology, Pharmacotherapy +15

Validation of the Brazilian version of mini-test CASI-S

Alfredo Damasceno, Adriane Maira Delicio, Daniel Ferraz de Campos Mazo et al. · Arquivos de Neuro-Psiquiatria · 2005 · 66 citations · Full text

Medicine, Neurology, Psychiatry +17

Accuracy of transient elastography-FibroScan®, acoustic radiation force impulse (ARFI) imaging, the enhanced liver fibrosis (ELF) test, APRI, and the FIB-4 index compared with liver biopsy in patients with chronic hepatitis C

Taisa Grotta Ragazzo, Denise Cerqueira Paranaguá‐Vezozzo, Fabiana Roberto Lima et al. · Clinics · 2017 · 65 citations · Full text

Medicine, Pathology, Diagnostic Imaging +16